Faron Pharmaceuticals Oy (FARN)
Industry Biotechnology
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell
210.00p
Buy
220.00p
0.00p (+0.00%)
Faron Pharmaceuticals Oy is a clinical stage biopharmaceutical company developing novel treatments for medicalconditions. The company currently has a pipeline focusing on acute organ traumas,vascular damage and cancer immunotherapy.
Prices updated at 19 May 2025, 12:24 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
No data available
Valuation
No data available
Profit margins data table
| Year | Gross margin (%) | Operating margin (%) | Net margin (%) | EBITDA margin (%) | EBITDA |
|---|---|---|---|---|---|
| 2024 | - | - | - | - | -22m |
| 2023 | - | - | - | - | -28m |
| 2022 | - | - | - | - | -27m |
| 2021 | - | - | - | - | -21m |
| 2020 | - | - | - | - | -17m |
| 2019 | - | - | - | - | -13m |
| 2018 | - | -103,426.32 | -105,715.79 | -104,542.11 | -20m |
| 2017 | - | - | - | - | -21m |
| 2016 | - | -1,019.22 | -1,064.92 | -1,046.32 | -10m |
Valuation data table
| Year | Price / Sales | Price earnings | Price / Cash flow |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
| 2019 | - | - | - |
| 2018 | 915.92 | - | - |
| 2017 | 316.84 | - | - |
| 2016 | 65.61 | - | - |
| 2015 | 84.69 | - | - |
Price/Forward earnings (YTD)
-3.22
Returns
Debt profile
Returns data table
| Year | Return on assets (%) | Return on equity (%) | Return on invested capital (%) |
|---|---|---|---|
| 2024 | -227.96 | - | - |
| 2023 | -287.97 | - | - |
| 2022 | -234.98 | - | - |
| 2021 | -196.71 | -3,961.50 | -536.18 |
| 2020 | -182.43 | - | - |
| 2019 | -145.65 | -1,340.27 | -378.98 |
| 2018 | -175.51 | -785.84 | -413.43 |
| 2017 | -137.50 | -320.47 | -236.68 |
| 2016 | -66.33 | -103.56 | -86.32 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | - |
| 2023 | - |
| 2022 | - |
| 2021 | 4.52 |
| 2020 | - |
| 2019 | 6.34 |
| 2018 | 21.69 |
| 2017 | 3.14 |
| 2016 | 1.87 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
